Ayana T Ruffin

6PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 06, 2026
TLR9 Agonists Potentiate Adoptive T Cell Therapy in Cancer through a B Cell-CD2 Costimulatory Axis.

|Dec 19, 2025
High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.

Emily Greene, Natalie K Horvat, Deon Bryant Doxie

|Dec 05, 2025
T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy.

Megen C Wittling, Amalia M Rivera-Reyes, Megan M Wyatt

|Feb 19, 2025
Dysfunctional CD11c-CD21- extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer.

Ayana T Ruffin, Allison N Casey, Sheryl R Kunning

|Jan 30, 2024
IL15 and IL21: Better When Membrane-Tethered Together on Antitumor T Cells.

Ayana T Ruffin, Megen C Wittling, Anna C Cole

|Dec 01, 2022
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment.

Ayana T Ruffin, Housaiyin Li, Lazar Vujanovic

Pageof 1

Frequent Collaborators

4 joint publications

Chrystal M Paulos

3 joint publications

Megen C Wittling

3 joint publications

Anna C Cole

3 joint publications

Gregory B Lesinski